Dr Ngozwana is an international expert onthe African Pharmaceutical industry, who has served as a consultant to the World Health Organization (WHO), United Nations Industrial Development Organization (UNIDO), the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the United States Pharmacopeia Convention (USP) among others. As the International lead consultant for UNIDO, Dr. Ngozwana co-authored the Pharmaceutical Manufacturing Plan for Africa that was adopted by the African Union heads of state and government in 2012. The plan was the output of the extensive research and analytical work he conducted on the African pharmaceutical industry. His recent UN assignment was as part of an expert team of three appointed by WHO to develop the Ethiopian Pharmaceutical Sector Strategy and Action Plan. This document was adopted by the Ethiopian government as a blueprint for developing the Ethiopian pharmaceutical sector; and is now incorporated into the Ethiopian Growth and Transformation Plan II. His last assignment with UNIDO involvedthe development of Ghana’s Pharmaceutical Sector Development Strategy; andfor USP, the development of a Thought Leadership Paper (pending publication) titled, The Next Frontiers for the Public Health Medicines Market: Rethinking priorities for improved access to quality-assured medicines for universal access.Dr Ngozwana has extensive contacts and networks through the African pharmaceutical and healthcare landscape, with regulators, procurement bodies, industry and various leading key opinion leaders. Prior to his consulting career, he worked for then JSE listed Cipla Medpro as its Deputy Chief Executive Officer. He is passionate about the development of the African pharmaceutical industry; access to quality assured medicines on the continent and has made significant contributions in developing the Industry.